Tentex Royal
$ 51,00 – $ 71,00Price range: $ 51,00 through $ 71,00
Tetracycline
$ 43,00 – $ 182,00Price range: $ 43,00 through $ 182,00
Terramycin
$ 54,00 – $ 97,00Price range: $ 54,00 through $ 97,00
Terramycin is a highly effective antibiotic ointment formulated to combat a variety of localized bacterial infections. It contains oxytetracycline, which works by inhibiting the growth of microorganisms responsible for inflammation and discomfort. This medication is primarily utilized for the treatment of superficial ocular infections, such as conjunctivitis and blepharitis. The fast-acting formula helps to rapidly alleviate symptoms like redness and swelling while targeting the underlying cause of the condition. By eliminating harmful bacteria, Terramycin promotes the healing process and helps protect sensitive tissues from further damage.
Active substance: tetracycline
SKU:
Terramycin
Category: Antibiotics
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Terramycin belongs to the tetracycline class of anti-infective agents containing oxytetracycline as its primary active constituent. It is formulated as an ophthalmic preparation designed to manage surface ocular bacterial infections under specific therapeutic parameters established by regulatory guidelines. Within the United States healthcare framework, Terramycin is dispensed in accordance with applicable federal and state regulations under professional medical supervision.
This reference document provides objective pharmacologic information regarding the mechanism, clinical indications, administrative guidelines, and safety considerations of Terramycin. Patients and healthcare providers should evaluate these parameters to ensure proper therapeutic application and minimize clinical risks.
| Parameter | Details |
|---|---|
| Drug name | Terramycin |
| Active ingredient (INN) | Oxytetracycline (with Polymyxin B Sulfate) |
| Therapeutic class | Tetracycline antibacterial / anti-infective agent |
| Dosage form | Ophthalmic ointment |
| Route of administration | Ophthalmic (topical ocular application) |
| Primary purpose | Treatment of superficial bacterial infections of the eye |
| Prescription status | Dispensed in accordance with applicable federal and state regulations |
Clinical Overview and Pharmacological Profile
How the drug works
The mechanism of action of Terramycin relies on the bacteriostatic properties of oxytetracycline combined with the bactericidal activity of polymyxin B sulfate. Oxytetracycline reversibly binds to the 30S ribosomal subunit of susceptible microorganisms, effectively inhibiting bacterial protein synthesis by interfering with the binding of aminoacyl-tRNA to the ribosomal acceptor site. Simultaneously, polymyxin B sulfate interacts with the phospholipid components of bacterial cell membranes, altering membrane permeability and causing osmotic disruption, particularly in Gram-negative bacteria such as Pseudomonas aeruginosa. This dual mechanism broadens the antimicrobial spectrum and minimizes the emergence of resistant bacterial strains during superficial ocular treatment.
Main uses
Terramycin ophthalmic ointment is indicated for the treatment of superficial ocular infections involving the conjunctiva, cornea, and palpebral margins. Specific FDA-approved indications include bacterial conjunctivitis, keratitis, blepharitis, and dacryocystitis caused by susceptible pathogens such as Staphylococcus aureus, Streptococcus pneumoniae, Escherichia coli, and Haemophilus influenzae. Use of this product for non-ocular conditions or deep intraocular infections represents an off-label application that is not approved by the FDA and must only be considered under explicit medical instruction by a prescribing physician.
What happens in the body
Following topical ocular administration into the conjunctival sac, Terramycin provides direct antimicrobial activity at the local tissue site. Systemic absorption of oxytetracycline and polymyxin B sulfate through intact corneal and conjunctival epithelia is extremely low. Consequently, systemic pharmacokinetic parameters such as plasma half-life, hepatic metabolism, and volume of distribution are clinically negligible under standard ophthalmic dosing regimens. Small quantities of the drug cleared via the nasolacrimal duct into the gastrointestinal tract undergo minimal systemic uptake, and any absorbed active fraction is eliminated predominantly by renal glomerular filtration.
Dosing schedule
The dosing schedule for Terramycin must be determined by a licensed prescriber based on the severity of the ocular infection and clinical response. The typical administrative regimen involves applying a small strip–approximately one-half inch–of the ophthalmic ointment directly into the lower conjunctival sac of the affected eye two to four times daily. Prior to application, thoroughly wash hands with soap and water. Care must be exercised to avoid touching the tip of the ointment tube to the eye, eyelid, fingers, or any foreign surface, as contamination of the tube contents may lead to secondary ocular infection.
Primary Indications and Safety Parameters
Adverse reactions
The administration of Terramycin ophthalmic ointment may be accompanied by localized adverse reactions. Patients frequently report transient ocular stinging, burning, mild irritation, or localized redness immediately following application. Due to the ointment vehicle, temporary blurring of vision is expected upon instillation and generally resolves as the medication spreads over the ocular surface. Allergic hypersensitivity reactions, including contact dermatitis, eyelid swelling (edema), and severe conjunctival hyperemia, occur infrequently. Extended or repeated use of topical antibacterial agents may facilitate fungal or non-susceptible bacterial superinfections, requiring clinical re-evaluation.
Compatibility with other medicines
Because systemic absorption of topically applied Terramycin is minimal, systemic drug-drug interactions are generally non-significant. However, physical and pharmacological interactions may occur when multiple ophthalmic preparations are administered simultaneously. The application of Terramycin ointment immediately before or after other eye drops can impede liquid drop absorption or wash out active ingredients. A separation interval of at least 5 to 10 minutes between different ophthalmic formulations is recommended. Concomitant use of topical corticosteroids may mask clinical signs of infection or suppress immune responses, increasing the risk of uncontrolled microbial progression.
Important precautions
Terramycin is contraindicated in individuals with a demonstrated history of hypersensitivity to oxytetracycline, other tetracyclines, polymyxin B sulfate, or any component of the ointment base. Use of this medication should be discontinued immediately if severe local allergic reactions or systemic hypersensitivity manifestations develop. Patients must avoid wearing contact lenses during active ocular infection treatment unless specifically permitted by an eye care specialist. Therapy should not extend beyond the duration prescribed to prevent the selection of resistant microbial strains and secondary fungal overgrowth.
Special populations
Safety and effectiveness of Terramycin ophthalmic ointment in pregnant or lactating women have not been established through comprehensive controlled clinical studies. Topical application should be limited to situations where potential clinical benefits clearly outweigh potential fetal or infant risks. Pediatric administration requires individualized assessment and monitoring by a healthcare professional. Elderly patients generally do not require specific dosage adjustments for topical ophthalmic use, though baseline age-related changes in tear production or ocular surface integrity should be monitored.
Safety Guidelines and Patient Information
Red flags
Patients receiving Terramycin should monitor for clinical signs that necessitate urgent medical evaluation. Emergency care must be sought immediately if any of the following warning signs manifest:
- Swelling of the face, lips, tongue, or throat indicative of severe systemic anaphylaxis
- Difficulty breathing or acute respiratory distress
- Severe, sudden, or worsening eye pain
- Marked change in visual acuity or sudden loss of vision
- Severe, rapidly spreading rash or skin peeling near the periocular region
- Purulent ocular discharge that significantly worsens despite adherence to therapy
If you skip a dose
If a dose of Terramycin ointment is missed, the scheduled application should be performed as soon as it is remembered. If the time of realization is close to the next scheduled dose, the missed application should be omitted, and the regular administration pattern resumed. Patients must not apply a double amount of ointment or increase application frequency to compensate for a missed dose, as excessive application increases local irritation risks without enhancing therapeutic efficacy.
Storage and expiration
Terramycin ophthalmic ointment should be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F), with temporary excursions permitted between 15°C and 30°C (59°F to 86°F). The container must be kept tightly closed after each use to protect the formulation from environmental exposure, heat, and direct light. The product should not be frozen. Any unused ointment must be discarded after the expiration date printed on the tube crimp and outer packaging, or beyond the recommended open-container discard timeframe established by pharmacy protocols.
Common Questions
Is temporary blurred vision expected after applying Terramycin ointment?
Yes. Temporary blurring of vision is a common physical effect caused when the ointment base coats the corneal surface. This effect typically dissipates within several minutes as the drug spreads across the ocular surface. Patients should refrain from driving or operating machinery until visual clarity is fully restored.
What action should be taken if ocular symptoms fail to improve after several days?
If symptoms persist without noticeable clinical improvement within 48 to 72 hours, or if the ocular condition deteriorates, the patient should contact the prescribing physician. Lack of response may indicate infection caused by a non-susceptible pathogen, a fungal superinfection, or an incorrect diagnosis requiring diagnostic reassessment.
Can contact lenses be worn during treatment with Terramycin?
Contact lens wear is generally contraindicated during active ocular infections to prevent corneal abrasion, pathogen entrapment, and delayed healing. Furthermore, ointment components may adhere to lens materials. Lenses should only be re-inserted after the infection has fully resolved and approval is granted by an eye care provider.
Can Terramycin ophthalmic ointment be applied to non-ocular skin lesions?
Terramycin ophthalmic ointment is specifically formulated and sterile-tested for ocular administration. Applying ophthalmic formulations off-label to non-ocular dermatologic lesions should only occur under explicit medical authorization, as different tissue concentrations and base properties are required for dermatologic conditions.
How should Terramycin be timed relative to other prescribed eye drops?
When multiple ophthalmic medications are prescribed, liquid eye drops should always be administered before applying Terramycin ointment. A delay of 5 to 10 minutes between liquid drops and ointment application is recommended to prevent liquid dilution and ensure optimal drug retention on the corneal surface.
Information on this page is for reference and does not replace an assessment by a licensed healthcare professional.
In accordance with FDA requirements.
Additional information
| Dosage |
250mg |
|---|---|
| Package |
180 pills ,360 pills |
| Ενεργός Ουσία |
Related products
Augmentin
$ 56,00 – $ 678,00Price range: $ 56,00 through $ 678,00
Active substance: amoxicillin, clavulanate
More Details
This product has multiple variants. The options may be chosen on the product page
Azithromycin DT
$ 60,00 – $ 972,00Price range: $ 60,00 through $ 972,00
Active substance: Azithromycin
More Details
This product has multiple variants. The options may be chosen on the product page
Biaxin
$ 107,00 – $ 427,00Price range: $ 107,00 through $ 427,00
Active substance: Clarithromycin
More Details
This product has multiple variants. The options may be chosen on the product page
Cefadroxil
$ 41,00 – $ 349,00Price range: $ 41,00 through $ 349,00
Active substance: cefadroxil
More Details
This product has multiple variants. The options may be chosen on the product page
Cephadex
$ 16,00 – $ 48,00Price range: $ 16,00 through $ 48,00
Active substance: cephalexin
More Details
This product has multiple variants. The options may be chosen on the product page
Cephalexin
$ 39,00 – $ 349,00Price range: $ 39,00 through $ 349,00
Active substance: cephalexin
More Details
This product has multiple variants. The options may be chosen on the product page
Chloromycetin
$ 52,00 – $ 242,00Price range: $ 52,00 through $ 242,00
Active substance: chloramphenicol
More Details
This product has multiple variants. The options may be chosen on the product page
Ciloxan Ophthalmic Solution
$ 50,00 – $ 63,00Price range: $ 50,00 through $ 63,00
Active substance: Ciprofloxacin hydrochloride
More Details
This product has multiple variants. The options may be chosen on the product page
